Shenzhen Chipscreen Biosciences Co.,Ltd. Posted 19.3 Million Yuan Net Loss in First Half of 2022

Shenzhen Chipscreen Biosciences Co.,Ltd. (深圳微芯生物科技股份有限公司) (688321.SH) reported a net loss of 19.3 million yuan in the first half of 2022, widening 169.7% year-on-year.

Meanwhile, the company posted 215.9 million yuan in revenue, up 17.8% year-on-year.

At the end of the reporting period, it had 2.2 billion yuan in total assets and 798.3 million yuan in total liabilities, with a liability-to-asset ratio of 36%.